Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 6 Next >
The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
Tickers IONS
Tags IONS Benzinga Analyst Ratings
From Benzinga
IONS Stock Earnings: Ionis Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
Tickers IONS
Tags NASDAQ:IONS Market News Earnings Reports
From InvestorPlace
The Latest Analyst Ratings For Ionis Pharmaceuticals
Tickers IONS
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
Genetic Medicines Focused-Ionis Pharmaceuticals' Fatty Liver Candidate Lowers Excess Liver Fat, Midstage Study Data Shows
Tickers IONS NEWS
Tags why it's moving General IONS
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Ionis Pharmaceuticals
Tickers IONS
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Earnings Scheduled For February 21, 2024
Tickers ACVA ADI AGI AGR
Tags ICLR AWR LIVN
From Benzinga
JP Morgan Maintains Neutral Rating for Ionis Pharmaceuticals: Here's What You Need To Know
Tickers IONS
Tags Benzinga BZI/AAR/UPDATE IONS
From Benzinga
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
Tickers BIIB IONS NEWS
Tags General Benzinga IONS
From Benzinga
Rare Disease Focused Ionis Pharmaceuticals Gears Up for FDA Submission After Donidalorsen Outperforms Placebo In Swollen Vessels Study
Tickers IONS NEWS
Tags Biotech Expert Ideas Reiteration
From Benzinga
Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 8 Analysts
Tickers IONS
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
Tickers ALNY ARM CPRI IONS
Tags Financials CPRI MCO
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ABBV ALNY CVS GILD
Tags MRNA BZI/AUOA IONS
From Benzinga
3 Stocks to Buy Now Before They Become Tomorrow’s Trillion-Dollar Companies
Tickers IONS TSM UNH
Tags NASDAQ:IONS,NYSE:UNH,NYSE:TSM Market News IONS
From InvestorPlace
Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential
Tickers ALNY AZN IONS NEWS
Tags General Analyst Ratings Benzinga
From Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
Tickers AZN IONS NEWS
Tags IONS Benzinga why it's moving
From Benzinga
Ionis' Strategic Shift Praised by Analysts For Donidalorsen's Global Reach
Tickers IONS TAK
Tags Market News Briefs Large Cap
From Benzinga
Where Ionis Pharmaceuticals Stands With Analysts
Tickers IONS
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat
Tickers ARKG ARKK ARKQ DKNG
Tags Benzinga DKNG IONS
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags IONS Benzinga Analyst Ratings
From Benzinga
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
Tickers ARKG ARKK CRSP EVS
Tags News ARKG NRIX
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Tickers ABBV ADBE ADSK AKAM
Tags NKE SUN ALNY
From Benzinga
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
Tickers ALNY AZN IONS NVS
Tags News Large Cap RHHVF
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Benzinga IONS BZI/AAR
From Benzinga
Why Ionis Pharmaceuticals Stock Popped Today
Tickers IONS
Tags Market News Movers News
From Benzinga
Ionis Pharmaceuticals' Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Action
Tickers IONS
Tags Market News Movers Biotech
From Benzinga
The 7 Most Hated Stocks by Institutional Traders
Tickers GS IONS LLY PDD
Tags TMUS TOST PTON
From InvestorPlace
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
Tickers ALNY IONS RHHBF RHHBY
Tags Analyst Ratings General IONS
From Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
Tickers ACCD ARKG ARKK ARKW
Tags DraftKings Pacific Biosciences of California ETFs
From Benzinga
Analyst Upgrades Ionis Pharmaceuticals To Buy Amid Key Pipeline Developments: Eplontersen And Donidalorsen Show Promising Outlook
Tickers ALNY AZN IONS
Tags Market News Equities Markets
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Tickers A ABR ADBE AIV
Tags PRFT Intraday Update GE
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.